Szingapúr - angol - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - acitretin - capsule - 25 mg - acitretin 25 mg

Málta - angol - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - acitretin - capsule - acitretin 25 mg - antipsoriatics

Egyesült Államok - angol - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - acitretin (unii: lch760e9t7) (acitretin - unii:lch760e9t7) - acitretin 10 mg - acitretin capsules, usp are indicated for the treatment of severe psoriasis in adults. because of significant adverse effects associated with its use, acitretin capsules, usp should be prescribed only by those knowledgeable in the systemic use of retinoids. in females of reproductive potential, acitretin capsules, usp should be reserved for non-pregnant patients who are unresponsive to other therapies or whose clinical condition contraindicates the use of other treatments (see boxed contraindications and warnings — acitretin capsules, usp can cause severe birth defects). most patients experience relapse of psoriasis after discontinuing therapy. subsequent courses, when clinically indicated, have produced efficacy results similar to the initial course of therapy. pregnancy category x: (see boxed contraindications and warnings.) acitretin is contraindicated in patients with severely impaired liver or kidney function and in patients with chronic abnormally elevated blood lipid values (see boxed warnings: hepato

Egyesült Államok - angol - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - acitretin (unii: lch760e9t7) (acitretin - unii:lch760e9t7) - acitretin 10 mg - acitretin capsules are indicated for the treatment of severe psoriasis in adults. because of significant adverse effects associated with its use, acitretin capsules should be prescribed only by those knowledgeable in the systemic use of retinoids. in females of reproductive potential, acitretin capsules should be reserved for non-pregnant patients who are unresponsive to other therapies or whose clinical condition contraindicates the use of other treatments (see boxed contraindications and warnings — acitretin capsules can cause severe birth defects). most patients experience relapse of psoriasis after discontinuing therapy. subsequent courses, when clinically indicated, have produced efficacy results similar to the initial course of therapy. pregnancy category x ( see boxed contraindications and warnings) acitretin is contraindicated in patients with severely impaired liver or kidney function and in patients with chronic abnormally elevated blood lipid values (see boxed warnings: hepatotoxicity, warnings: lipids and possible cardiovascular effects , and precautions ). an increased risk of hepatitis has been reported to result from combined use of methotrexate and etretinate. consequently, the combination of methotrexate with acitretin is also contraindicated (see precautions: drug interactions ). since both acitretin and tetracyclines can cause increased intracranial pressure, their combined use is contraindicated (see warnings: pseudotumor cerebri ). acitretin is contraindicated in cases of hypersensitivity (e.g., angioedema, urticaria) to the preparation (acitretin or excipients) or to other retinoids.

Szingapúr - angol - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - acitretin - capsule - 10 mg - acitretin 10 mg

Egyesült Államok - angol - NLM (National Library of Medicine)

actavis pharma, inc. - acitretin (unii: lch760e9t7) (acitretin - unii:lch760e9t7) - acitretin 10 mg

Egyesült Államok - angol - NLM (National Library of Medicine)

avkare - acitretin (unii: lch760e9t7) (acitretin - unii:lch760e9t7) - acitretin 10 mg - acitretin capsules, usp are indicated for the treatment of severe psoriasis in adults. because of significant adverse effects associated with its use, acitretin capsules, usp should be prescribed only by those knowledgeable in the systemic use of retinoids. in females of reproductive potential, acitretin capsules, usp should be reserved for non-pregnant patients who are unresponsive to other therapies or whose clinical condition contraindicates the use of other treatments (see boxed contraindications and warnings — acitretin capsules, usp can cause severe birth defects). most patients experience relapse of psoriasis after discontinuing therapy. subsequent courses, when clinically indicated, have produced efficacy results similar to the initial course of therapy. pregnancy category x: ( see boxed contraindications and warnings. ) acitretin is contraindicated in patients with severely impaired liver or kidney function and in patients with chronic abnormally elevated blood lipid values (see boxed warnings: hepatotoxicity, warnings: lipids and possible cardiovascular effects, and precautions). an increased risk of hepatitis has been reported to result from combined use of methotrexate and etretinate. consequently, the combination of methotrexate with acitretin is also contraindicated (see precautions: drug interactions). since both acitretin and tetracyclines can cause increased intracranial pressure, their combined use is contraindicated (see warnings: pseudotumor cerebri). acitretin is contraindicated in cases of hypersensitivity (e.g., angioedema, urticaria) to the preparation (acitretin or excipients) or to other retinoids .

Egyesült Államok - angol - NLM (National Library of Medicine)

sigmapharm laboratories, llc - acitretin (unii: lch760e9t7) (acitretin - unii:lch760e9t7) - acitretin 10 mg - acitretin capsules, usp are indicated for the treatment of severe psoriasis in adults. because of significant adverse effects associated with its use, acitretin capsules, usp should be prescribed only by those knowledgeable in the systemic use of retinoids. in females of reproductive potential, acitretin capsules, usp should be reserved for non-pregnant patients who are unresponsive to other therapies or whose clinical condition contraindicates the use of other treatments (see boxed contraindications and warnings — acitretin capsules, usp can cause severe birth defects). most patients experience relapse of psoriasis after discontinuing therapy. subsequent courses, when clinically indicated, have produced efficacy results similar to the initial course of therapy. pregnancy category x:  ( see boxed contraindications and warnings. ) acitretin is con